(Q47449775)

16 January 2018

title

Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes (English)

1 reference

16 January 2018

1 reference

Stefan Matecki

1

1 reference

16 January 2018

Roy W R Dudley

2

1 reference

16 January 2018

Maziar Divangahi

3

1 reference

16 January 2018

Renald Gilbert

4

1 reference

16 January 2018

Josephine Nalbantoglu

5

1 reference

16 January 2018

George Karpati

6

1 reference

16 January 2018

Basil J Petrof

7

1 reference

16 January 2018

publication date

21 May 2004

1 reference

16 January 2018

American Journal of Physiology - Lung Cellular and Molecular Physiology

published in

1 reference

16 January 2018

volume

287

1 reference

16 January 2018

issue

3

1 reference

16 January 2018

page(s)

L569-76

1 reference

16 January 2018

DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Effective adenovirus-mediated gene expression in adult murine skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Sensitivity and reproducibility in adenoviral infectious titer determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Practical problems in the respiratory care of patients with muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00117.2004

10.1152/AJPLUNG.00117.2004

21 January 2018

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018